86 related articles for article (PubMed ID: 38509729)
41. HDAC Inhibition Improves the Sarcoendoplasmic Reticulum Ca
Meraviglia V; Bocchi L; Sacchetto R; Florio MC; Motta BM; Corti C; Weichenberger CX; Savi M; D'Elia Y; Rosato-Siri MD; Suffredini S; Piubelli C; Pompilio G; Pramstaller PP; Domingues FS; Stilli D; Rossini A
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29385061
[TBL] [Abstract][Full Text] [Related]
42. Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis.
Khalil H; Kanisicak O; Prasad V; Correll RN; Fu X; Schips T; Vagnozzi RJ; Liu R; Huynh T; Lee SJ; Karch J; Molkentin JD
J Clin Invest; 2017 Oct; 127(10):3770-3783. PubMed ID: 28891814
[TBL] [Abstract][Full Text] [Related]
43. Role of the histone deacetylase inhibitor valproic acid in high-fat diet-induced hypertension via inhibition of HDAC1/angiotensin II axis.
Choi J; Park S; Kwon TK; Sohn SI; Park KM; Kim JI
Int J Obes (Lond); 2017 Nov; 41(11):1702-1709. PubMed ID: 28720877
[TBL] [Abstract][Full Text] [Related]
44. Interleukin-10 Inhibits Bone Marrow Fibroblast Progenitor Cell-Mediated Cardiac Fibrosis in Pressure-Overloaded Myocardium.
Verma SK; Garikipati VNS; Krishnamurthy P; Schumacher SM; Grisanti LA; Cimini M; Cheng Z; Khan M; Yue Y; Benedict C; Truongcao MM; Rabinowitz JE; Goukassian DA; Tilley D; Koch WJ; Kishore R
Circulation; 2017 Sep; 136(10):940-953. PubMed ID: 28667100
[TBL] [Abstract][Full Text] [Related]
45. Chronic intermittent hypoxia induces liver fibrosis in mice with diet-induced obesity via TLR4/MyD88/MAPK/NF-kB signaling pathways.
Kang HH; Kim IK; Lee HI; Joo H; Lim JU; Lee J; Lee SH; Moon HS
Biochem Biophys Res Commun; 2017 Aug; 490(2):349-355. PubMed ID: 28623125
[TBL] [Abstract][Full Text] [Related]
46. Physiological role of reactive oxygen species as promoters of natural defenses.
Roy J; Galano JM; Durand T; Le Guennec JY; Lee JC
FASEB J; 2017 Sep; 31(9):3729-3745. PubMed ID: 28592639
[TBL] [Abstract][Full Text] [Related]
47. Enhanced expression and phosphorylation of Sirt7 activates smad2 and ERK signaling and promotes the cardiac fibrosis differentiation upon angiotensin-II stimulation.
Wang H; Liu S; Liu S; Wei W; Zhou X; Lin F; Wang J; Chen J; Zhang G; Pang Y
PLoS One; 2017; 12(6):e0178530. PubMed ID: 28582407
[TBL] [Abstract][Full Text] [Related]
48. IL-18 cleavage triggers cardiac inflammation and fibrosis upon β-adrenergic insult.
Xiao H; Li H; Wang JJ; Zhang JS; Shen J; An XB; Zhang CC; Wu JM; Song Y; Wang XY; Yu HY; Deng XN; Li ZJ; Xu M; Lu ZZ; Du J; Gao W; Zhang AH; Feng Y; Zhang YY
Eur Heart J; 2018 Jan; 39(1):60-69. PubMed ID: 28549109
[TBL] [Abstract][Full Text] [Related]
49. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.
Chioncel O; Lainscak M; Seferovic PM; Anker SD; Crespo-Leiro MG; Harjola VP; Parissis J; Laroche C; Piepoli MF; Fonseca C; Mebazaa A; Lund L; Ambrosio GA; Coats AJ; Ferrari R; Ruschitzka F; Maggioni AP; Filippatos G
Eur J Heart Fail; 2017 Dec; 19(12):1574-1585. PubMed ID: 28386917
[TBL] [Abstract][Full Text] [Related]
50. Selective inhibition of HDAC2 by magnesium valproate attenuates cardiac hypertrophy.
Raghunathan S; Goyal RK; Patel BM
Can J Physiol Pharmacol; 2017 Mar; 95(3):260-267. PubMed ID: 28177689
[TBL] [Abstract][Full Text] [Related]
51. The protective role of liquiritin in high fructose-induced myocardial fibrosis via inhibiting NF-κB and MAPK signaling pathway.
Zhang Y; Zhang L; Zhang Y; Xu JJ; Sun LL; Li SZ
Biomed Pharmacother; 2016 Dec; 84():1337-1349. PubMed ID: 27810791
[TBL] [Abstract][Full Text] [Related]
52. Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in China.
Lu X; Ning Z; Li Z; Cao H; Wang X
Intractable Rare Dis Res; 2016 Aug; 5(3):185-91. PubMed ID: 27672541
[TBL] [Abstract][Full Text] [Related]
53. Efficacy and Safety of Novel Oral Anticoagulants in Patients With Atrial Fibrillation and Heart Failure: A Meta-Analysis.
Savarese G; Giugliano RP; Rosano GM; McMurray J; Magnani G; Filippatos G; Dellegrottaglie S; Lund LH; Trimarco B; Perrone-Filardi P
JACC Heart Fail; 2016 Nov; 4(11):870-880. PubMed ID: 27614940
[TBL] [Abstract][Full Text] [Related]
54. Effects of blood-pressure-lowering treatment in hypertension: 9. Discontinuations for adverse events attributed to different classes of antihypertensive drugs: meta-analyses of randomized trials.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2016 Oct; 34(10):1921-32. PubMed ID: 27454050
[TBL] [Abstract][Full Text] [Related]
55. Phosphocreatine attenuates angiotensin II-induced cardiac fibrosis in rat cardiomyocytes through modulation of MAPK and NF-κB pathway.
Fei AH; Wang FC; Wu ZB; Pan SM
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(12):2726-33. PubMed ID: 27383329
[TBL] [Abstract][Full Text] [Related]
56. Hic-5 is required for myofibroblast differentiation by regulating mechanically dependent MRTF-A nuclear accumulation.
Varney SD; Betts CB; Zheng R; Wu L; Hinz B; Zhou J; Van De Water L
J Cell Sci; 2016 Feb; 129(4):774-87. PubMed ID: 26759173
[TBL] [Abstract][Full Text] [Related]
57. TGFβ1 regulates Scleraxis expression in primary cardiac myofibroblasts by a Smad-independent mechanism.
Zeglinski MR; Roche P; Hnatowich M; Jassal DS; Wigle JT; Czubryt MP; Dixon IM
Am J Physiol Heart Circ Physiol; 2016 Jan; 310(2):H239-49. PubMed ID: 26566727
[TBL] [Abstract][Full Text] [Related]
58. CXCL9 Regulates TGF-β1-Induced Epithelial to Mesenchymal Transition in Human Alveolar Epithelial Cells.
O'Beirne SL; Walsh SM; Fabre A; Reviriego C; Worrell JC; Counihan IP; Lumsden RV; Cramton-Barnes J; Belperio JA; Donnelly SC; Boylan D; Marchal-Sommé J; Kane R; Keane MP
J Immunol; 2015 Sep; 195(6):2788-96. PubMed ID: 26268659
[TBL] [Abstract][Full Text] [Related]
59. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.
Mohammed SF; Hussain S; Mirzoyev SA; Edwards WD; Maleszewski JJ; Redfield MM
Circulation; 2015 Feb; 131(6):550-9. PubMed ID: 25552356
[TBL] [Abstract][Full Text] [Related]
60. Chidamide, a histone deacetylase inhibitor, functions as a tumor inhibitor by modulating the ratio of Bax/Bcl-2 and P21 in pancreatic cancer.
Zhao B; He T
Oncol Rep; 2015 Jan; 33(1):304-10. PubMed ID: 25384499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
